Efficacy and safety of mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant recipient

Transplant Proc. 1998 Dec;30(8):4087-9. doi: 10.1016/s0041-1345(98)01351-7.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Acute Disease
  • Bone Marrow Transplantation / immunology*
  • Chronic Disease
  • Cyclosporine / therapeutic use
  • Drug Therapy, Combination
  • Graft vs Host Disease / drug therapy*
  • Graft vs Host Disease / prevention & control
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Leukemia / therapy*
  • Living Donors
  • Mycophenolic Acid / adverse effects
  • Mycophenolic Acid / analogs & derivatives*
  • Mycophenolic Acid / therapeutic use
  • Nuclear Family
  • Prednisolone / therapeutic use

Substances

  • Immunosuppressive Agents
  • Cyclosporine
  • Prednisolone
  • Mycophenolic Acid